Biodesix (BDSX) EBIAT (2019 - 2025)
Historic EBIAT for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$8.7 million.
- Biodesix's EBIAT rose 1503.22% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.5 million, marking a year-over-year increase of 977.43%. This contributed to the annual value of -$42.9 million for FY2024, which is 1767.15% up from last year.
- Per Biodesix's latest filing, its EBIAT stood at -$8.7 million for Q3 2025, which was up 1503.22% from -$11.5 million recorded in Q2 2025.
- In the past 5 years, Biodesix's EBIAT registered a high of -$7.0 million during Q1 2021, and its lowest value of -$20.3 million during Q4 2022.
- For the 5-year period, Biodesix's EBIAT averaged around -$12.4 million, with its median value being -$11.5 million (2025).
- Its EBIAT has fluctuated over the past 5 years, first tumbled by 19300.68% in 2021, then surged by 5506.44% in 2023.
- Quarter analysis of 5 years shows Biodesix's EBIAT stood at -$13.3 million in 2021, then crashed by 53.12% to -$20.3 million in 2022, then skyrocketed by 55.06% to -$9.1 million in 2023, then grew by 9.72% to -$8.3 million in 2024, then dropped by 5.64% to -$8.7 million in 2025.
- Its EBIAT stands at -$8.7 million for Q3 2025, versus -$11.5 million for Q2 2025 and -$11.1 million for Q1 2025.